FR2652747B1 - APPLICATION OF ACTIVE AGENTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AUTOIMMUNE DISEASES. - Google Patents

APPLICATION OF ACTIVE AGENTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AUTOIMMUNE DISEASES.

Info

Publication number
FR2652747B1
FR2652747B1 FR8913075A FR8913075A FR2652747B1 FR 2652747 B1 FR2652747 B1 FR 2652747B1 FR 8913075 A FR8913075 A FR 8913075A FR 8913075 A FR8913075 A FR 8913075A FR 2652747 B1 FR2652747 B1 FR 2652747B1
Authority
FR
France
Prior art keywords
preparation
treatment
application
active agents
autoimmune diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8913075A
Other languages
French (fr)
Other versions
FR2652747A1 (en
Inventor
Edgardo D Carosella
Mireille-Nee-Panero Latour
Jacques Armand
Claude Mawas
Daniel Olive
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Priority to FR8913075A priority Critical patent/FR2652747B1/en
Publication of FR2652747A1 publication Critical patent/FR2652747A1/en
Application granted granted Critical
Publication of FR2652747B1 publication Critical patent/FR2652747B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FR8913075A 1989-10-06 1989-10-06 APPLICATION OF ACTIVE AGENTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AUTOIMMUNE DISEASES. Expired - Fee Related FR2652747B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8913075A FR2652747B1 (en) 1989-10-06 1989-10-06 APPLICATION OF ACTIVE AGENTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AUTOIMMUNE DISEASES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913075A FR2652747B1 (en) 1989-10-06 1989-10-06 APPLICATION OF ACTIVE AGENTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AUTOIMMUNE DISEASES.

Publications (2)

Publication Number Publication Date
FR2652747A1 FR2652747A1 (en) 1991-04-12
FR2652747B1 true FR2652747B1 (en) 1995-03-31

Family

ID=9386152

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8913075A Expired - Fee Related FR2652747B1 (en) 1989-10-06 1989-10-06 APPLICATION OF ACTIVE AGENTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AUTOIMMUNE DISEASES.

Country Status (1)

Country Link
FR (1) FR2652747B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4028955A1 (en) * 1990-09-12 1992-03-19 Boehringer Mannheim Gmbh MONOCLONAL ANTIBODIES AGAINST THE INTERLEUKIN 2 RECEPTOR

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2188941B (en) * 1986-04-14 1990-06-06 Bayer Ag Monoclonal antibodies recognizing human interleukin-2-receptor
FR2616330B1 (en) * 1987-06-12 1990-12-21 Immunotech Sa ACTIVE AGENT AND CONTAINING MEDICINE FOR PREVENTING OR COMBATING ORGAN REJECTION REJECTION IN MEN
WO1989009622A1 (en) * 1988-04-15 1989-10-19 Protein Design Labs, Inc. Il-2 receptor-specific chimeric antibodies

Also Published As

Publication number Publication date
FR2652747A1 (en) 1991-04-12

Similar Documents

Publication Publication Date Title
FR2622798B1 (en) DOSAGE FORM AND OSMOTIC DELIVERY DEVICE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
OA09123A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases.
FR2698780B1 (en) CATHETER FOR THE TREATMENT OF A PATHOLOGICAL TISSUE.
MA21682A1 (en) PROCESS FOR THE PREPARATION OF THERAPEUTIC AGENTS DERIVED FROM QUAINCLIDINE.
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
MA26658A1 (en) VALEROHYDRAZINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, MEDICAMENT FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES CONTAINING THEM, AND THEIR USE FOR PREPARING SUCH A MEDICINAL PRODUCT
FR2628973B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN USE, AND PROCESS FOR THE PREPARATION OF SUCH A COMPOSITION
FR2717080B1 (en) Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer's disease.
FR2660192B1 (en) LIPOSOMIAL FORMULATION FOR TOPICAL OR VAGINAL ADMINISTRATION OF DRUGS.
FR2634988B1 (en) PODAL DEVICE FOR THE TREATMENT OF PAINFUL AREES OF THE BOTTOM OF THE FOOT
FR2759906B1 (en) USE OF MILNACIPRAN AND DERIVATIVES THEREOF FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CERTAIN PSYCHIATRIC DISEASES
FR2744361B1 (en) APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE
FR2714603B1 (en) Dermatological composition and its use for the preparation of a medicament.
FR2652747B1 (en) APPLICATION OF ACTIVE AGENTS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AUTOIMMUNE DISEASES.
FR2716623B1 (en) Use of a tricyclic derivative for obtaining medicaments intended for the treatment of mnemo-cognitive disorders.
FR2644060B1 (en) MEDICINE, ESPECIALLY FOR THE TREATMENT OF CUTANEOUS, EYE AND GENITAL HERPES VIRUS DISEASES
FR2718024B1 (en) Medicine and pharmaceutical composition for the treatment of inflammation.
DE68905076T2 (en) Pharmaceutical composition for the treatment of skin wounds.
FR2706303B1 (en) Use of Efaroxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease.
FR2744362B1 (en) APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE
BE1003340A3 (en) NEW THERAPEUTIC USE OF ALPHA-AMINOFLUOROCETONES.
FR2713087B1 (en) Use of selegiline and its derivatives for the preparation of a medicament intended for the treatment of psoriasis.
FR2639829B1 (en) NEW MEDICINE FOR THE TREATMENT OF PROSTATE LESION
FR2656529B3 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF OCULAR ACCOMODATION DISORDERS.

Legal Events

Date Code Title Description
ST Notification of lapse